Ocugen CSO to Participate in 4th Annual Gene Therapy for Ophthalmic Disorders Conference


MALVERN, PA — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN) announced that Arun Upadhyay, PhD, Ocugen’s Chief Scientific Officer, Head of Research, Development and Medical, will be among the featured speakers at the 4th Annual Gene Therapy for Ophthalmic Disorders conference, which is being held October 3-5, 2023 in Boston, Mass.

Dr. Upadhyay will be speaking during two sessions:

Topic: Endpoints for Gene Therapy Clinical Trials in Ophthalmology
Date: October 3, 2023
Time: 9 a.m. – noon ET

Session: Fine-tuning the Design of First-in-Human Clinical Studies
Topic: Striking a Balance with Ascending Dose Studies
Date: October 5, 2023
Time: 11:20 – 11:50 a.m. ET

Discover more at www.ocugen.com.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.

READ:  Ocugen CEO to Address Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference